Anthropic is moving ahead with a November stock market debut targeting a valuation of roughly $2 trillion and a raise of up to $100 billion, the Wall Street Journal reported on September 18, 2026, making it what would be the largest initial public offering in history. The Wall Street Journal reported on September 18, 2026, that Anthropic is moving ahead with its planned IPO for November, targeting a valuation of roughly $2 trillion and a raise of up to $100 billion. Anthropic pushed its timeline to November from an earlier October target, a shift that lets the company present fresh third-quarter numbers to investors before locking in pricing. The offering's proposed scale is arresting even by recent standards: Anthropic wants to raise a record $100 billion in the process, a figure larger than total IPO proceeds marketwide in every year except 2020 and 2021.
The announcement arrived barely a week after a cascade of internal warnings that drew international attention. On September 9, 2026, Jacob Coxon, who spent three years doing pretraining research at both OpenAI and Anthropic, quit his job and posted on X that both companies are "gambling with our lives." Anthropic alignment-science lead Evan Hubinger responded publicly: "Jacob is correct here -- we really do earnestly believe AI could kill all humans! I personally think it is greater than 10 percent within the next decade. I believe Anthropic is trying its best, but we do not yet have a plan to solve alignment for superintelligence and are not clearly on track to." Samuel Marks, Anthropic's scalable-oversight lead, added that "AI developers believe their technology could cause human extinction (or similarly bad outcomes)." The disclosures are not outliers: the largest academic survey of its kind, covering 2,778 researchers, put the median AI extinction risk estimate at 5 percent, while Anthropic's own alignment lead has said more than 10 percent.
The collision of those two data points, a $2 trillion fundraise and a greater-than-10-percent extinction estimate from the person whose job is to prevent it, raises a concrete governance question. Anthropic is organized as a Delaware Public Benefit Corporation, a structure that provides a degree of legal insulation: Anthropic has legally identified its public benefit purpose as "the responsible development and maintenance of advanced AI for the long-term benefit of humanity," a framework that provides the board an explicit legal shield against shareholder derivative lawsuits that might otherwise claim a breach of fiduciary duty if the company delays or cancels the release of a highly profitable but potentially dangerous AI model. Separately, any offering would likely involve a single class of common stock for public investors while a trust retains a separate share class and board-election rights, a governance profile where public shareholders would not control a board majority.
Advisers close to the deal are not treating the safety uproar as a commercial liability. The Claude maker might actually view the past weeks as elevating the case for its IPO rather than dampening it, arguing that safety is improved via the transparency of being a public company. Skeptics push back on both the valuation math and the safety framing: the diligence question is not only the $2 trillion headline, but the gap between a $47 billion May run rate and the $100 billion to $120 billion December figure investors are underwriting, an investor projection rather than Anthropic's own guidance. Figures such as Meta's Yann LeCun consider the extinction risk overblown, and even Microsoft partner Mustafa Suleyman calls superintelligence an "anti-goal" while still working toward it.
When the person whose job title is 'alignment lead' says the odds of the company killing everyone are better than one in ten, and the company's response is to schedule a roadshow, that is the risk factor worth reading twice.